Lumida
/CLB
⌘K
Core Laboratories Inc

Core Laboratories Inc

CLB
$12.50USD-0.24%-0.03 today

MARKET CAP

573.6M

P/E (TTM)

20.5x

FWD P/E

DAY RANGE

$12 – $13

52W RANGE

$10
$20

AI Summary

Stalk
Buy NowMedium

CLB is in a Stage 4 decline but is mean-reversion eligible, warranting a tactical bullish stance. The post-capitulation pattern and extreme oversold context signal supply exhaustion and potential stabilization around the washout low, and short-term price action shows a strong recovery bar with volume confirming initial acceptance, supporting immediate participation on this rebound.

  • Q4 2025 revenue reached $138.3M, up 3% QoQ and 7% YoY.
  • Repurchased $2.7M in stock in Q2 2026, seventh consecutive buyback.
  • Q2 2026 net income fell to $5.1M, down 72% QoQ.
Full analysis →

Buying

5

institutions

Selling

5

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
AI

Ariel Investments, LLC

Q2 2026

BUY14.07 M163.97 M+904.56 K-25.9%1.63%
BI

Blackrock, Inc.

Q2 2026

BUY7.46 M86.91 M+251.62 K-28.2%0.00%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL485.03 K5.65 M+-618.86 K-69.5%0.00%
FA

Fisher Asset Management, LLC

Q2 2026

SELL447.95 K5.22 M+-288.80 K-57.8%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY381.92 K4.45 M+211.81 K+55.8%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY64.81 K755.03 K+12.88 K-13.4%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY39.71 K667.69 K+19.85 K+109.7%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL22.68 K247.64 K+-514.00-36.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL14.50 K168.93 K+-36.10 K-80.1%0.00%
MM

Millennium Management LLC

Q2 2026

SELL0.000.00+-23.80 K-100.0%0.00%